Login

Atherosclerosis

Atherosclerotic lesions lead to narrowing of the blood vessels and are caused by the accumulation of lipoproteins, monocyte derived macrophages and lymphocytes within the arterial wall. Atherosclerosis is behind clinical manifestations including stroke and myocardial infarcation. Find resources for your atherosclerosis research below.

100643-71-8
5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-
CAS No: 100643-71-8
MW: 310.82055999999994
Purity: 98%
Pricing and Availability
101932-71-2
Calyculin A
CAS No: 101932-71-2
MW:
Purity: >99.5%
Pricing and Availability
102146-07-6
1H-Purine-2,6-dione, 8-cyclopentyl-3,9-dihydro-1,3-dipropyl-
CAS No: 102146-07-6
MW: 304.3874
Purity: 95%
Pricing and Availability
10238-21-8
5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide
CAS No: 10238-21-8
MW: 494.00351999999987
Purity: 98%
Pricing and Availability
103-90-2
N-Acetyl-4-hydroxyaniline
CAS No: 103-90-2
MW: 151.1626
Purity: 98%
Pricing and Availability
1037624-75-1
R428
CAS No: 1037624-75-1
MW: 506.6446
Purity: 99%
Pricing and Availability
104062-70-6
Carbamic acid, [(1S)-1-formylpentyl]-, 1,1-dimethylethyl ester
CAS No: 104062-70-6
MW: 215.2893
Purity:
Pricing and Availability
104594-70-9
2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, 2-phenylethyl ester
CAS No: 104594-70-9
MW: 284.3065
Purity: 98%
Pricing and Availability
1073154-85-4
Defactinib
CAS No: 1073154-85-4
MW: 510.4927
Purity: 99%
Pricing and Availability
1073612-91-5
4-[[4-oxo-2-thioxo-3-[3-(trifluoromethyl)benzyl]thiazolidin-5-ylidene]methyl]benzoicacid
CAS No: 1073612-91-5
MW: 423.4287
Purity: 98%
Pricing and Availability